Home > Insider Trading > Takeda Pharmaceutical Co Ltd > Profile

Takeda Pharmaceutical Co Ltd (TAK)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Hedge Fund Popularity

Display

13F filing is ongoing

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period: Filing is Ongoing

Last updated on May 09, 2025, 3:47 pm based on SEC 13F filings Last update: May 09, 2025, 3:47 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Leucadia National Ian Cumming And Joseph Steinberg	13,391	$199,124		0%

Institutional Investors' Holdings

Filing Period: Filing is Ongoing

No.	Name	Shares	Value	% Port
1.	Goldman Sachs Group Inc	5,320,793	$79,120,193	0.01%
2.	Blackrock, Inc.	2,630,833	$39,120,481	0%
3.	Envestnet Asset Management Inc	891,183	$13,251,885	0%
4.	Federated Investors Inc	541,919	$8,058,336	0.02%
5.	Crossmark Global Holdings, Inc.	396,833	$5,900,907	0.1%

News See All

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2024 Earnings Call Transcript

Christopher O’Reilly: Thank you very much for taking time out of their busy schedule to join our earnings announcement for FY '24 for Takeda. I'm the master of ceremony, Head of IR.

Keep Reading →

May 10th, 2025 - News Transcripts

12 Best Low Price Pharma Stocks To Invest In Right Now

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...

Keep Reading →

February 25th, 2025 - Hedge Funds News

12 Best Japanese Stocks To Buy in 2025

As the dangers of natural disasters increase and the expenses of social security continue to rise, the International Monetary Fund says Japan has to take quick action to strengthen its fiscal situation...

Keep Reading →

February 15th, 2025 - Hedge Funds News

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Earnings Call Transcript

Christopher O’Reilly: [Foreign Language] Let me start, I’d like to remind everyone that we’ll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform...

Keep Reading →

January 31st, 2025 - News Transcripts

12 Most Profitable Pharmaceutical Stocks Right Now

Keep Reading →

November 29th, 2024 - Hedge Funds News

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2025 Earnings Call Transcript

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2025 Earnings Call Transcript October 31, 2024Takeda Pharmaceutical Company Limited beats earnings expectations.

Keep Reading →

November 2nd, 2024 - News Transcripts

10 Best Japanese Stocks To Buy Now

As we navigate through 2024, Japan’s economic landscape is emerging as a compelling arena for investors. Despite facing a rough start to the year, the nation is showing signs of a promising rebound.

Keep Reading →

September 20th, 2024 - Hedge Funds News

10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers

The pharmaceutical industry is one of the most interesting sectors to invest in.

Keep Reading →

August 27th, 2024 - News Quantitative Investing

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q1 2025 Earnings Call Transcript

Christopher O’Reilly: Thank you very much for taking time out of your very busy schedule to join us for this first quarter earnings call by Takeda for FY ‘24. I’m the master of ceremony today.

Keep Reading →

August 5th, 2024 - News Transcripts